Page last updated: 2024-10-22

amsacrine and Leishmaniasis, Cutaneous

amsacrine has been researched along with Leishmaniasis, Cutaneous in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mauël, J1
Denny, W1
Gamage, S1
Ransijn, A1
Wojcik, S1
Figgitt, D1
Ralph, R1

Other Studies

1 other study available for amsacrine and Leishmaniasis, Cutaneous

ArticleYear
9-Anilinoacridines as potential antileishmanial agents.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:5

    Topics: Amsacrine; Animals; Antiprotozoal Agents; Cell Line; Humans; Leishmania tropica; Leishmaniasis, Cuta

1993